Highly efficient recombinant production and purification of streptococcal cysteine protease streptopain with increased enzymatic activity

Protein Expression and Purification
Michael D Lane, Burckhard Seelig

Abstract

Streptococcus pyogenes produces the cysteine protease streptopain (SpeB) as a critical virulence factor for pathogenesis. Despite having first been described seventy years ago, this protease still holds mysteries which are being investigated today. Streptopain can cleave a wide range of human proteins, including immunoglobulins, the complement activation system, chemokines, and structural proteins. Due to the broad activity of streptopain, it has been challenging to elucidate the functional results of its action and precise mechanisms for its contribution to S. pyogenes pathogenesis. To better study streptopain, several expression and purification schemes have been developed. These methods originally involved isolation from S. pyogenes culture but were more recently expanded to include recombinant Escherichia coli expression systems. While substantially easier to implement, the latter recombinant approach can prove challenging to reproduce, often resulting in mostly insoluble protein and poor purification yields. After extensive optimization of a wide range of expression and purification conditions, we applied the autoinduction method of protein expression and developed a two-step column purification scheme that reliably produc...Continue Reading

References

Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·V KapurJ M Musser
Mar 1, 1994·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·D GerlachK H Schmidt
Sep 13, 2001·The Journal of Biological Chemistry·M NomizuE Ziomek
Jan 29, 2003·The Journal of Infectious Diseases·Rita G KansalMalak Kotb
Mar 7, 2003·The Journal of Biological Chemistry·Chiu-Yueh ChenWoei-Jer Chuang
May 26, 2005·Protein Expression and Purification·F William Studier
Oct 29, 2005·The Lancet Infectious Diseases·Jonathan R CarapetisMartin Weber
Jun 5, 2007·Protein Expression and Purification·Paul G Blommel, Brian G Fox
Dec 28, 2007·The Journal of Biological Chemistry·Yutaka TeraoShigetada Kawabata
Aug 20, 2008·Cellular Microbiology·Randall J OlsenJames M Musser
Feb 25, 2009·The Journal of Biological Chemistry·Chih-Chieh WangWoei-Jer Chuang
Nov 14, 2012·The Journal of Biological Chemistry·Yaping Lin-MoshierJonathan S Marchant
Apr 4, 2014·Clinical Microbiology Reviews·Mark J WalkerVictor Nizet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.